HEART FAILURE WITH REDUCED EJECTION FRACTION (HFREF)
Clinical trials for HEART FAILURE WITH REDUCED EJECTION FRACTION (HFREF) explained in plain language.
Never miss a new study
Get alerted when new HEART FAILURE WITH REDUCED EJECTION FRACTION (HFREF) trials appear
Sign up with your email to follow new studies for HEART FAILURE WITH REDUCED EJECTION FRACTION (HFREF), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can video calls keep heart patients healthier after hospital?
Disease control Recruiting nowThis study is testing whether regular video check-ins with a nurse help people with heart failure manage their condition better than traditional phone calls. Researchers will compare two groups of about 368 patients after they leave the hospital: one group gets scheduled video ca…
Matched conditions: HEART FAILURE WITH REDUCED EJECTION FRACTION (HFREF)
Phase: NA • Sponsor: Federal University of Uberlandia • Aim: Disease control
Last updated Apr 03, 2026 20:40 UTC
-
Smart watch aims to keep heart failure patients out of hospital
Disease control Recruiting nowThis study is testing whether a smartwatch-like device, combined with artificial intelligence, can help people with chronic heart failure stay healthier and avoid hospital trips. About 205 adults with stable heart failure will either use the device for six months or receive their…
Matched conditions: HEART FAILURE WITH REDUCED EJECTION FRACTION (HFREF)
Sponsor: University of Salerno • Aim: Disease control
Last updated Apr 03, 2026 14:43 UTC
-
Heart and kidney patients tested on best pill schedule
Disease control Recruiting nowThis study aims to find the best daily schedule for taking the medication ramipril to help protect kidney function in people who have both chronic kidney disease and a type of heart failure. Researchers will compare taking one larger dose per day versus two smaller doses over 30 …
Matched conditions: HEART FAILURE WITH REDUCED EJECTION FRACTION (HFREF)
Phase: PHASE4 • Sponsor: Evi Liliek Wulandari • Aim: Disease control
Last updated Apr 02, 2026 14:57 UTC
-
New heart device aims to tame failing hearts
Disease control Recruiting nowThis study is testing whether a new medical device called the AccuCinch System can help people with a weakened heart pump (heart failure). About 400 participants will be randomly assigned to receive either the device plus standard medications or standard medications alone. Resear…
Matched conditions: HEART FAILURE WITH REDUCED EJECTION FRACTION (HFREF)
Phase: NA • Sponsor: Ancora Heart, Inc. • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
Heart failure breakthrough? new study tests smarter pacemaker
Disease control Recruiting nowThis study aims to find out which type of pacemaker works best for patients with heart failure and a specific electrical problem. Researchers will compare a newer pacing method (left bundle branch pacing) to the standard method (biventricular pacing) in 100 patients. They will us…
Matched conditions: HEART FAILURE WITH REDUCED EJECTION FRACTION (HFREF)
Phase: NA • Sponsor: University Hospital of Patras • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
New heart drug put to the test: can it repair a weakened heart?
Disease control Recruiting nowThis study is testing if adding the drug vericiguat to standard heart failure treatment helps improve the heart's structure and function. It will involve 60 adults with stable but weakened hearts who are already on standard medications. Researchers will compare those receiving th…
Matched conditions: HEART FAILURE WITH REDUCED EJECTION FRACTION (HFREF)
Phase: PHASE4 • Sponsor: University Medical Centre Ljubljana • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
Major heart study tests which common drug better prevents shocks and hospital trips
Disease control Recruiting nowThis study aims to find out which of two commonly used heart failure medications works better for patients who also have an implanted defibrillator. It will follow 2,000 participants for up to 3 years to see which drug leads to fewer defibrillator shocks, fewer hospital visits, a…
Matched conditions: HEART FAILURE WITH REDUCED EJECTION FRACTION (HFREF)
Phase: PHASE4 • Sponsor: University of Rochester • Aim: Disease control
Last updated Mar 24, 2026 12:03 UTC